ANKRD54 anticorps (AA 201-300) (Cy3)

N° du produit ABIN1416209

Détail du produit anti-ANKRD54 anticorps (Cy3)

Antigène: ANKRD54 (Ankyrin Repeat Domain 54 (ANKRD54))

Épitope: AA 201-300

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ANKRD54 est conjugé à/à la Cy3

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human ANKRD54

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur ANKRD54

Antigène: ANKRD54 (Ankyrin Repeat Domain 54 (ANKRD54))

Autre désignation: ANKRD54 (ANKRD54 Produits)

Synonymes: anticorps LIAR, anticorps C730048E16Rik, anticorps EST1068184, anticorps EST475269, anticorps Liar, anticorps RGD1309552, anticorps wu:fi33d09, anticorps zgc:110569, anticorps zgc:92735, anticorps ankyrin repeat domain 54, anticorps ANKRD54, anticorps Ankrd54, anticorps ankrd54

Sujet:

Synonyms: Ankrd54, ankyrin repeat domain 54, ankyrin repeat domain 54, Ankyrin repeat domain-containing protein 54, ANR54_HUMAN, LIAR.

Background: ANKRD54 is a 300 amino acid protein that contains four ankyrin repeats and is expressed as two alternatively spliced isoforms. The gene encoding human ANKRD54 maps to chromosome 22, which houses over 500 genes and is the second smallest human chromosome. Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, neurofibromatosis type 2, autism and schizophrenia. Additionally, translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia chromosome and the subsequent production of the novel fusion protein BCR-Abl, a potent cell proliferation activator found in several types of leukemias.

ID gène: 129138